10-Q: Clorox Q2 Earnings Dip Amid Macro Headwinds, GOJO Acquisition

Clorox reports a decline in Q2 net earnings and diluted EPS, driven by lower sales and higher costs, while announcing the strategic acquisition of GOJO Industries for $2.25 billion.

Summary

• Net sales decreased by 1% to $1,673 million for the three months ended December 31, 2025, and by 10% to $3,102 million for the six months ended December 31, 2025, compared to the prior year periods.
• Diluted net earnings per share (EPS) decreased by 16% to $1.29 for the three months and by 18% to $1.93 for the six months ended December 31, 2025.
• Gross margin declined by 60 basis points to 43.2% for the three months and by 230 basis points to 42.5% for the six months, primarily due to higher manufacturing and logistics costs.
• The company announced the acquisition of GOJO Industries, a leader in skin health and hygiene solutions, for approximately $2.25 billion in cash, expected to close before the end of fiscal year 2026, funded primarily through debt.
• Clorox completed the purchase of Procter & Gamble's 20% interest in the Glad bags and wraps venture for $476 million, following the venture agreement's expiration on January 31, 2026.
• The company continues its phased implementation of a new enterprise resource planning (ERP) system, with core U.S. operations transitioning, and expects to complete implementation this fiscal year with a total incremental transformational investment of approximately $580 million.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a challenging quarter with significant declines in key financial metrics, particularly net earnings and EPS. While strategic acquisitions and ERP implementation are positive long-term moves, the immediate financial performance and macroeconomic headwinds present concerns.

Positives

• International segment net sales increased by 7% for the three months and 3% for the six months, with segment adjusted EBIT up 48% for the three months, driven by strong shipments in Latin America, favorable price mix, and foreign exchange rates.
• Health and Wellness segment net sales increased by 2% for the three months, with volume also up 2%, primarily due to incremental shipments related to the final phase of the ERP transition and strong Professional Products performance.
• Selling and administrative expenses decreased by 6% ($18 million) for the three months and 4% ($22 million) for the six months, primarily due to lower costs related to digital capabilities and productivity enhancements investment and lower incentive compensation.
• Net cash provided by operations increased slightly to $404 million for the six months ended December 31, 2025, compared to $401 million in the prior period, driven by lower working capital and lower tax payments.
• The company maintains strong credit ratings and access to capital markets, with a $1,200 million revolving credit agreement fully available and in compliance with all covenants.

Negatives

• Consolidated net sales decreased by 1% for the three months and 10% for the six months ended December 31, 2025, primarily due to lower consumption, lower shipments following ERP transition in prior fiscal year, and the divestiture of the Better Health VMS business.
• Net earnings attributable to Clorox decreased by 18.6% to $157 million for the three months and by 18.8% to $237 million for the six months ended December 31, 2025.
• Diluted EPS decreased by 16% to $1.29 for the three months and by 18% to $1.93 for the six months ended December 31, 2025.
• Gross margin declined by 60 basis points to 43.2% for the three months and 230 basis points to 42.5% for the six months, primarily due to higher manufacturing and logistics costs and lower volume.
• Household segment net sales decreased by 6% for the three months and 13% for the six months, with segment adjusted EBIT down 54% and 55% respectively, mainly due to lower consumption, unfavorable price mix, and higher manufacturing and logistics costs.
• Lifestyle segment net sales decreased by 5% for the three months and 14% for the six months, with volume decreases primarily due to lower consumption and lower shipments.
• Current liabilities exceeded current assets by $619 million as of December 31, 2025, primarily due to the $476 million Glad venture agreement terminal obligation.
• The company is lapping significant cyberattack insurance recoveries from the prior year, impacting the year-over-year comparison of Other (income) expense, net.

Risks

• Risks associated with the GOJO acquisition, including potential termination, failure to satisfy regulatory conditions, integration challenges, rating agency actions, failure to realize anticipated benefits/synergies, unexpected costs, litigation, disruption to operations, difficulty retaining key personnel/customers/suppliers, negative impact on stock price/operating results, and credit rating decline.
• Unfavorable general economic and geopolitical conditions, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel/energy costs, interest rate fluctuations, foreign currency exchange rate fluctuations, weather events, natural disasters, disease outbreaks, terrorism, and unstable geopolitical conditions.
• Impact of market and category declines, and the company's product and geographic mix on its ability to meet sales growth targets.
• Ability to successfully execute or realize anticipated benefits of strategic or transformational initiatives, including the ERP transition and related timing/volume of shipment movement.
• Risks related to supply chain issues, product shortages, and disruptions due to increased supply chain dependencies and reliance on single-source suppliers.
• Risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches, or data breaches.
• Dependence on key customers, with Walmart Inc. and its affiliates accounting for 26% of consolidated net sales.
• Environmental matters, including potential additional remediation costs up to approximately $28 million over an estimated 30-year period for one site, and potential responsibility for more than its 24.3% share at another site.
• The company's indebtedness and credit rating, and its ability to access capital markets and other funding sources, as well as the cost of capital.

Future Outlook

The company anticipates that the operating environment will remain volatile and challenging for the remainder of fiscal year 2026, as consumers may face greater pressure due to continued macroeconomic uncertainty impacting spending. It plans to continue investing in its brands, capabilities, and people to deliver consistent, profitable growth over time. The ERP system implementation is on track to be completed this fiscal year, and the GOJO acquisition is expected to close before the end of fiscal year 2026.

Management Comments

• "The Company continues to monitor macroeconomic conditions as a result of volatility in capital markets and developments in international trade policy."
• "While inflationary headwinds have moderated, consumers continue to feel pressure as continued macroeconomic uncertainty impacts spending and prices remain elevated."
• "The Company anticipates that the operating environment will remain volatile and challenging."
• "The Company has not experienced significant disruptions in its operations during the first half of fiscal year 2026."
• "The Company remains in the stabilization phase and is on track to complete implementation [of the ERP system] this fiscal year."
• "The pending acquisition of GOJO Industries... and upcoming purchase of The Procter & Gamble Company's (P&G) interest in the venture agreement for the Company's Glad business reflect the Company's commitment to continue evolving its portfolio to deliver long-term value for shareholders."
• "The Company believes it will have the funds necessary to support its shortand long-term liquidity and operating needs, including its ability to invest in its brands, capabilities and people to deliver consistent profitable growth over time."

Industry Context

StockSavvy.ai notes that Clorox's performance reflects broader trends in the consumer staples sector, where companies are navigating persistent inflationary pressures, evolving consumer spending habits, and supply chain complexities. The decline in gross margin due to higher manufacturing and logistics costs is a common challenge across the industry, as is the moderation of inflationary headwinds but continued consumer price sensitivity. The strategic acquisition of GOJO Industries aligns with a trend of consumer goods companies seeking to expand into adjacent, higher-growth categories like health and hygiene solutions, potentially diversifying revenue streams and leveraging existing distribution networks. The divestiture of the Better Health VMS business indicates a focus on core competencies and portfolio optimization, a strategy many peers employ to streamline operations and improve profitability.

Comparison to Industry Standards

• Clorox's gross margin of 43.2% (Q2 FY26) and 42.5% (H1 FY26) is generally in line with or slightly below some major consumer packaged goods (CPG) peers. For example, Procter & Gamble (P&G) typically reports gross margins in the mid-to-high 40s, while Kimberly-Clark (KMB) often sees margins in the mid-30s to low 40s. Unilever (UL) also tends to be in the mid-40s. The decline in Clorox's margin suggests it is experiencing similar or perhaps more pronounced cost pressures than some of its larger, more diversified competitors.
• The 26% sales concentration with Walmart Inc. is a significant customer dependency, which is higher than many diversified CPG companies. While common for large CPG players to have substantial sales through major retailers, this level of concentration can expose the company to increased negotiation pressure and risks associated with a single customer's performance or strategic shifts. For instance, companies like Coca-Cola or PepsiCo, while having large retail partners, typically have a more diversified customer base globally.
• The strategic move to acquire GOJO Industries for $2.25 billion, a leader in skin health and hygiene, positions Clorox to strengthen its presence in the health and wellness sector. This mirrors similar strategic expansions by peers, such as Reckitt Benckiser's focus on hygiene and health brands, or Unilever's acquisitions in personal care, aiming for categories with strong growth potential and higher margins.

Corporate Governance

Legal Proceedings

• The company is involved in certain environmental matters, including response actions at various locations, with recorded liabilities totaling $27 million.
• One environmental matter in Alameda County, California, has a recorded liability of $12 million, with potential additional undiscounted costs up to approximately $28 million over an estimated 30-year period.
• Another environmental matter in Dickinson County, Michigan, has a recorded liability of $10 million, where the company is jointly and severally liable for 24.3% of costs, with a possibility of greater exposure that is not estimable.
• The company is subject to various other legal proceedings, claims, and loss contingencies (e.g., contractual arrangements, product liability, patents, trademarks, advertising, labor, environmental, health and safety), but management believes their ultimate disposition will not have a material adverse effect on the consolidated financial statements.

Related Party Transactions

• The venture agreement with The Procter & Gamble Company (P&G) for the Glad bags and wraps business expired on January 31, 2026. Clorox will purchase P&G's 20% interest for $476 million. P&G previously provided R&D support and received a royalty.

Stakeholder Impact

• Shareholders: Negative impact from decreased net earnings and diluted EPS. Potential long-term value creation from strategic acquisitions (GOJO, Glad full ownership) and ERP transformation, but also increased debt from financing these initiatives.
• Employees: Continued investment in capabilities and people. ERP implementation may involve changes to processes and procedures.
• Customers: Lower consumption noted in some segments. Continued investment in product innovation and advertising to support brands. Potential benefits from expanded product offerings through GOJO acquisition.
• Suppliers: Participation in the voluntary supply chain finance (SCF) program allows suppliers to receive early payment from a financial institution, potentially improving their liquidity.
• Creditors: Increased debt financing for the GOJO acquisition and Glad venture purchase will increase leverage, though the company maintains strong credit ratings and compliance with covenants.

Next Steps

• Complete the acquisition of GOJO Industries before the end of fiscal year 2026, subject to regulatory approval and customary closing conditions.
• Pay $476 million in cash for P&G's 20% interest in the Glad business during the third quarter of fiscal year 2026.
• Complete the phased implementation of the new ERP system this fiscal year.
• Continue to monitor macroeconomic conditions, including volatility in capital markets, international trade policy, and inflationary pressures.
• Continue to invest in brands, capabilities, and people to deliver consistent, profitable growth.

Key Dates

Recommendation

The company faces significant near-term headwinds, including declining sales, gross margin compression, and lower EPS, exacerbated by macroeconomic uncertainty and the lapping of prior-period benefits. However, strategic moves like the GOJO acquisition and full ownership of Glad, coupled with ongoing ERP transformation, signal a commitment to long-term growth and portfolio optimization. The increased debt for these initiatives warrants caution. Given the mixed outlook with clear challenges but also strategic investments for future growth, a "hold" recommendation is appropriate for investors to monitor the execution of these strategies and the impact of the volatile operating environment.

Keywords

Clorox, CLX, Consumer Products, Household Goods, GOJO Industries, Acquisition, Glad, P&G Venture, ERP System, Financial Results, Earnings, Net Sales, Gross Margin, Diluted EPS, Supply Chain, Macroeconomic Conditions, Debt Financing, Stock Repurchase, Dividends, Environmental Liabilities, Cyberattack, Q2 2026